A previous version of the story incorrectly stated that the researchers received a patent for their classifier in 2017. They filed an application in 2017 but have not yet received a patent. We regret the error.
NEW YORK (GenomeWeb) – A group led by Mount Sinai researchers has used nasal brush collection and RNA sequencing (RNA-seq) to identify a genetic classifier for asthma. With further validation studies, the team believes its tool could lead to the development of a minimally invasive biomarker test that would cost only around $30.